Analysts expect Scribe Therapeutics, Inc. to report revenue of 3.88 M for Q3 26, against a range of 3.60 M to 4.16 M. The most recent reported quarter, Q2 26, came in at 1.90 M, a 35.2% miss against the 2.93 M consensus.
| Metric | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|
| Reported (Actual) | 2.20 M | 1.90 M | - | - | - | - |
| High Estimate | - | 3.14 M | 4.16 M | 3.82 M | 2.64 M | 2.31 M |
| Low Estimate | - | 2.72 M | 3.60 M | 3.41 M | 2.42 M | 1.94 M |
| Consensus Estimate | - | 2.93 M | 3.88 M | 3.61 M | 2.53 M | 2.13 M |
Analysts expect Scribe Therapeutics, Inc. to report earnings per share of -0.82 for Q3 26, against a range of -0.85 to -0.79. The most recent reported quarter, Q2 26, came in at -2.62, a 22.3% beat against the -3.37 consensus.
| Metric | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|
| Reported (Actual) | -6.25 | -2.62 | - | - | - | - |
| High Estimate | - | -3.09 | -0.79 | -0.78 | -0.64 | -0.64 |
| Low Estimate | - | -3.65 | -0.85 | -0.94 | -0.72 | -0.76 |
| Consensus Estimate | - | -3.37 | -0.82 | -0.86 | -0.68 | -0.70 |
Pull Wall Street consensus for Scribe Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SCTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SCTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SCTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();